Click image to view it in full size

The growing burden of cardiovascular disease and incidences of myocardial infraction is driving demand for cardiac troponin diagnostics tests, which have become the gold standard for myocardial infraction detection. Moreover, a high number of patients visiting emergency departments with chest pain complaints is increasing adoption of cardiac troponin diagnostics for rapid rule-in and rule-out of myocardial infraction. High sensitivity cardiac troponin assays provide rapid and accurate results and aids in elimination of low-risk patients. This in turn reduces the length of hospital stay, thereby reducing healthcare costs.

Point-of-care testing troponin diagnostics are estimated to gain traction owing to their applications in remote care and emergency care settings. Furthermore, the high sensitivity point of care testing provides accurate results in a shorter time. These tests are estimated to drive industry growth in the next few years owing to their benefits such as reduced turn around time and sensitivity.